AGD1: A Protein Involved in Neurotransmitter Signaling and Inflammation
AGD1: A Protein Involved in Neurotransmitter Signaling and Inflammation
MIR100HG (AGD1) is a protein that is expressed in the brain and is known for its role in the development and progression of various neurological disorders, including Alzheimer's disease. The AGD1 protein is a member of the G-protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a critical role in cellular signaling.
The AGD1 protein is composed of 194 amino acid residues and has a calculated molecular weight of 21.1 kDa. It is expressed in the brain and other tissues and is involved in a wide range of physiological processes, including cell signaling, neurotransmitter signaling, and inflammation.
One of the key functions of the AGD1 protein is its role in neurotransmitter signaling. AGD1 is involved in the regulation of neurotransmitter release from neurons, which is critical for the transmission of signals in the brain. It is thought to play a role in the regulation of dopamine release, which is involved in a variety of cognitive and behavioral processes, including motivation, emotion, and memory.
In addition to its role in neurotransmitter signaling, AGD1 is also involved in the regulation of inflammation. It is a potent chemoattractant for neutrophils, which are a type of white blood cell that play a critical role in immune defense and inflammation. AGD1 is also involved in the regulation of inflammation-related signaling pathways, which are important for the development of neuroinflammatory diseases, including Alzheimer's disease.
The AGD1 protein is also of interest because it is a potential drug target. Researchers are currently working to develop compounds that can selectively bind to AGD1 and inhibit its signaling activity. These compounds have the potential to be used to treat a wide range of neurological disorders, including Alzheimer's disease.
In conclusion, AGD1 is a protein that is expressed in the brain and is involved in a wide range of physiological processes, including neurotransmitter signaling and inflammation. It is also a potential drug target and has the potential to be used to treat a wide range of neurological disorders, including Alzheimer's disease. Further research is needed to fully understand the role of AGD1 in the development and progression of neurological disorders.
Protein Name: Mir-100-let-7a-2-mir-125b-1 Cluster Host Gene
More Common Targets
MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B
